KYTX
Faruqi & Faruqi Reminds Kyverna Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 – KYTX
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Kyverna To...
Read moreDetails
Kyverna Therapeutics, Inc. Investors with Large Losses Are Encouraged to Contact Shareholder Rights Law Firm Robbins LLP for Information About the KYTX Class Action Lawsuit
SAN DIEGO , Dec. 26, 2024 /PRNewswire/ -- Robbins LLP reminds investors that a shareholder filed a class action against Kyverna...
Read moreDetails
Kessler Topaz Meltzer & Check, LLP – Class Action Announcement for Kyverna Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Kyverna Therapeutics, Inc.
RADNOR, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs...
Read moreDetails
ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX
NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers...
Read moreDetails
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit
LOS ANGELES , Dec. 26, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses...
Read moreDetails
KYTX INVESTOR ALERT: Kirby McInerney LLP Notifies Kyverna Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the February...
Read moreDetails
Contact The Gross Law Firm by February 7, 2025 Deadline to Join Class Action Against Kyverna Therapeutics, Inc.(KYTX)
NEW YORK , Dec. 26, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kyverna...
Read moreDetails